Literature DB >> 1440864

Liver transplantation for hereditary tyrosinemia--early transplantation following the patient's stabilization.

E M Sokal1, R Bustos, F Van Hoof, J B Otte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1440864     DOI： 10.1097/00007890-199211000-00035

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation.

Authors:  F J van Spronsen; G P Smit; F A Wijburg; Y Thomasse; G Visser; H S Heymans
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Liver transplantation in nine Spanish patients with tyrosinaemia type I.

Authors:  C Pérez-Cerdá; B Merinero; P Sanz; M Castro; J Gangoiti; M J García; M Díaz; E Medina; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Liver transplantation for inborn errors of liver metabolism.

Authors:  Efienne M Sokal
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Nitisinone in the treatment of hereditary tyrosinaemia type 1.

Authors:  Patrick J McKiernan
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 7.  Quality of life after orthotopic liver transplantation in children. An overview of physical, psychological and social outcome.

Authors:  E M Sokal
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.